NCT07071077 · University of Delaware
Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans
What this study is about
The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.
View original scientific description
The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.
Interventions
BEHAVIORAL
Web-Based Storytelling Intervention
The Web-based storytelling group will access stories and educational materials on the study website.
BEHAVIORAL
Group-Based Storytelling Plus Intervention
The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.
Primary outcome measures
Systolic and Diastolic Blood Pressure
Time frame: 6 months
Blood pressure will be measured three times using a manual blood pressure monitor.
Adherence to Antihypertensive Medications (daily usage)
Time frame: 6 months
Medication adherence will be measured using Medication Electronic Measuring System (MEMS) caps
Adherence to Antihypertensive Medications (self reported)
Time frame: 6 months
Medication adherence will be measure through participant self report Domains of Subjective Extent of Nonadherence scale.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- African American/Black
- Diagnosed with Hypertension
- Prescribed medication for hypertension
Exclusion criteria
- Cognitive limitations that limit the ability to provide informed consent
- Unable to speak or read English
- Planning to relocate during the study period
Where
- Newark, Delaware
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jul 17, 2025 · Source of record for eligibility and locations